Linked Data API

Show Search Form

Search Results

1353505
registered interest false remove filter
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans his Department has for a covid-19 vaccine booster campaign in autumn 2021. more like this
tabling member constituency Central Ayrshire more like this
tabling member printed
Dr Philippa Whitford remove filter
uin 44364 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-10more like thismore than 2021-09-10
answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential Covid-19 booster vaccination programme on 30th June 2021, which can be found at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI’s interim advice is that COVID-19 boosters should first be offered to the most vulnerable. The JCVI advises a two staged approach, with individuals in Stage 1 offered a COVID-19 booster vaccine, and flu vaccine, as soon as possible from September, and individuals in Stage 2 offered a COVID-19 booster vaccine as soon as practicable after Stage 1, with equal emphasis on deployment of the flu vaccine where eligible.</p><p>Final decisions on the timing and scope and cohort eligibility, including the groups listed above, of any COVID-19 vaccine booster programme will be confirmed once the JCVI have provided their final advice, alongside considerations related to COVID-19 vaccine supply and approvals by the Medicines and Healthcare products Regulatory Agency.</p>
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-09-10T13:46:11.66Zmore like thismore than 2021-09-10T13:46:11.66Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4385
label Biography information for Dr Philippa Whitford more like this
1353507
registered interest false remove filter
date less than 2021-09-07more like thismore than 2021-09-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long term monitoring of immunity in people who have received different covid-19 vaccines for each dose. more like this
tabling member constituency Central Ayrshire more like this
tabling member printed
Dr Philippa Whitford remove filter
uin 44365 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-09-10more like thismore than 2021-09-10
answer text <p>The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose.</p><p>Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The antibody results will be published in due course.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-09-10T09:07:39.593Zmore like thismore than 2021-09-10T09:07:39.593Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4385
label Biography information for Dr Philippa Whitford more like this